Talus Bio logo

Talus Bio Funding & Investors

Seattle, WA

Talus Bio is a drug discovery biotech startup working on drug development for gene regulators. The company is building a data-enabled platform that focuses primarily on small molecule drug development in oncology.

talus.bio

Total Amount Raised: $27,781,502

Talus Bio Funding Rounds

  • Seed

    $11,200,000

    Seed Investors

    Two Bear Capital
    WRF Capital
    Y Combinator Continuity Fund
    BoxOne Ventures
    FundersClub
    NFX
    Rolling Bay Ventures
  • Grant

    $2,000,000

    Grant Investors

    NCATS
  • Grant

    $705,876

    Grant Investors

    National Institutes of Health (NIH)
    NCATS
  • Grant

    $2,294,310

    Grant Investors

    Andy Hill Cancer Research Endowment (CARE) Fund
  • Grant

    $2,000,000

    Grant Investors

    National Cancer Institute (NCI)
  • Grant

    $788,867

    Grant Investors

    National Institutes of Health (NIH)
    National Cancer Institute (NCI)
  • Seed

    $7,149,118

    Seed Investors

    NFX
    North South Ventures
  • Grant

    $255,831

    Grant Investors

    National Science Foundation (NSF)
  • Pre Seed

    $1,387,500

    Pre Seed Investors

    Fifty Years
    Boom Capital Ventures
Funding info provided by Diffbot.